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BACKGROUND 
Acute effects of spaceflight on the cardiovascular system have been studied extensively, but the combined chronic 
effects of spaceflight and aging are not well understood. Preparation for and participation in spaceflight activities are 
associated with changes in the cardiovascular system such as decreased carotid artery distensibility and decreased 
ventricular mass which may lead to an increased risk of cardiovascular disease. Additionally, astronauts who travel 
into space multiple times or for longer durations may be at an increased risk across their lifespan. To that end, the 
purpose of this study was to determine the incidence of common cardiovascular disease (CVD) outcomes among the 
NASA astronaut corps during their active career and through retirement.  
 
METHODS  
Cardiovascular disease outcomes were defined as reports of any of the following: myocardial infarction (MI), 
revascularization procedures (coronary artery bypass graft surgery [CABG] or percutaneous coronary intervention 
[PCI]), hypertension, stroke or transient ischemic attack [TIA], heart failure, or total CVD (as defined by the AHA - 
combined outcome of MI, Angina Pectoris, heart failure, stroke, and hypertension). Each outcome was identified 
individually from review of NASA’s Electronic Medical Record (EMR), EKG reports, and death certificates using 
ICD-9 codes as well as string searches of physician notes of astronaut exams that occurred between 1959 and 2016.  
 
RESULTS 
Of 338 NASA astronauts selected as of 2016, 9 reported an MI, 12 reported a revascularization procedure, (7 PCI 
and 5 CABG), 4 reported Angina (without MI), 5 reported heart failure, 9 reported stroke/TIA, and 96 reported 
hypertension. Total CVD was reported in 105 astronauts. No astronaut who had an MI or revascularization 
procedure flew a spaceflight mission following the event. All MI, revascularization, and stroke events occurred in 
male astronauts. When reviewing astronaut ECG reports, abnormal ECG reports were found in only 8% of records 
(n=430) and mainly among retired astronauts (82%), with marked sinus bradycardia being the reason for the 
abnormal classification. 
 
CONCLUSIONS  
As astronauts train for exploration-class missions that are estimated to last up to three years, it is important to 
understand health outcomes that occur in relation to spaceflight. There is a need to understand how aging affects 
these outcomes as well. It appears that current astronaut medical selection criteria and preventive measures keep the 
incidence of cardiovascular outcomes low. In order to determine whether this incidence is indeed low, two historical 
cohort studies are being conducted comparing astronauts to a cohort United States Air Force aviators and a 
prevention cohort from the Cooper Center. These studies will shed additional light on the risk for developing 
cardiovascular disease that astronauts face because of spaceflight and aging. 
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